316 related articles for article (PubMed ID: 22130710)
1. In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells.
Takayama N; Eto K
Methods Mol Biol; 2012; 788():205-17. PubMed ID: 22130710
[TBL] [Abstract][Full Text] [Related]
2. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors.
Takayama N; Nishikii H; Usui J; Tsukui H; Sawaguchi A; Hiroyama T; Eto K; Nakauchi H
Blood; 2008 Jun; 111(11):5298-306. PubMed ID: 18388179
[TBL] [Abstract][Full Text] [Related]
3. ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis.
Hong SH; Lee JH; Lee JB; Ji J; Bhatia M
J Cell Sci; 2011 May; 124(Pt 9):1445-52. PubMed ID: 21486943
[TBL] [Abstract][Full Text] [Related]
4. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
[TBL] [Abstract][Full Text] [Related]
5. Enhanced generation of hematopoietic cells from human hepatocarcinoma cell-stimulated human embryonic and induced pluripotent stem cells.
Lu M; Kardel MD; O'Connor MD; Eaves CJ
Exp Hematol; 2009 Aug; 37(8):924-36. PubMed ID: 19481135
[TBL] [Abstract][Full Text] [Related]
6. Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration.
Risueño RM; Sachlos E; Lee JH; Lee JB; Hong SH; Szabo E; Bhatia M
Stem Cells; 2012 Feb; 30(2):131-9. PubMed ID: 22131151
[TBL] [Abstract][Full Text] [Related]
7. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells.
Nakamura S; Takayama N; Hirata S; Seo H; Endo H; Ochi K; Fujita K; Koike T; Harimoto K; Dohda T; Watanabe A; Okita K; Takahashi N; Sawaguchi A; Yamanaka S; Nakauchi H; Nishimura S; Eto K
Cell Stem Cell; 2014 Apr; 14(4):535-48. PubMed ID: 24529595
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro.
Tokumoto Y; Ogawa S; Nagamune T; Miyake J
J Biosci Bioeng; 2010 Jun; 109(6):622-8. PubMed ID: 20471604
[TBL] [Abstract][Full Text] [Related]
9. Comparative study using Raman microspectroscopy reveals spectral signatures of human induced pluripotent cells more closely resemble those from human embryonic stem cells than those from differentiated cells.
Tan Y; Konorov SO; Schulze HG; Piret JM; Blades MW; Turner RF
Analyst; 2012 Oct; 137(19):4509-15. PubMed ID: 22888493
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
Jozefczuk J; Prigione A; Chavez L; Adjaye J
Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
[TBL] [Abstract][Full Text] [Related]
12. Human pluripotent stem cells for disease modelling and drug screening.
Maury Y; Gauthier M; Peschanski M; Martinat C
Bioessays; 2012 Jan; 34(1):61-71. PubMed ID: 22038777
[TBL] [Abstract][Full Text] [Related]
13. Megakaryocyte and platelet production from human cord blood stem cells.
Robert A; Cortin V; Garnier A; Pineault N
Methods Mol Biol; 2012; 788():219-47. PubMed ID: 22130711
[TBL] [Abstract][Full Text] [Related]
14. [In vitro differentiation into megakaryocytes and generation of platelets from CD34+ cells of umbilical cord blood].
Li X; Chen FP; Liu J; Wu XH; Jiang TB; Tang XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):776-81. PubMed ID: 17062951
[TBL] [Abstract][Full Text] [Related]
15. Generation of Megakaryocytes and Platelets from Human Pluripotent Stem Cells.
Pick M
Methods Mol Biol; 2016; 1307():371-8. PubMed ID: 24297316
[TBL] [Abstract][Full Text] [Related]
16. Generation of functional platelets from canine induced pluripotent stem cells.
Nishimura T; Hatoya S; Kanegi R; Sugiura K; Wijewardana V; Kuwamura M; Tanaka M; Yamate J; Izawa T; Takahashi M; Kawate N; Tamada H; Imai H; Inaba T
Stem Cells Dev; 2013 Jul; 22(14):2026-35. PubMed ID: 23409943
[TBL] [Abstract][Full Text] [Related]
17. Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes.
Nakagawa Y; Nakamura S; Nakajima M; Endo H; Dohda T; Takayama N; Nakauchi H; Arai F; Fukuda T; Eto K
Exp Hematol; 2013 Aug; 41(8):742-8. PubMed ID: 23618622
[TBL] [Abstract][Full Text] [Related]
18. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
Cheng L; Qasba P; Vanguri P; Thiede MA
J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
[TBL] [Abstract][Full Text] [Related]
19. Successful generation of donor specific hematopoietic stem cell lines from co-cultured bone marrow with human embryonic stem cell line: a new methodology.
Vanikar AV; Mishra VV; Firoz A; Shah VR; Dave SD; Patel RD; Kanodia KV; Patel JV; Patel CN; Trivedi HL
Transplant Proc; 2007 Apr; 39(3):658-61. PubMed ID: 17445567
[TBL] [Abstract][Full Text] [Related]
20. Genetic manipulation of megakaryocytes to study platelet function.
Liu J; DeNofrio J; Yuan W; Wang Z; McFadden AW; Parise LV
Curr Top Dev Biol; 2008; 80():311-35. PubMed ID: 17950378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
